These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11714536)

  • 1. The point mutation in the promoter region and the single nucleotide polymorphism in exon 1 of the cytokeratin 19 gene in human lung cancer cell lines.
    Fujita J; Dohmoto K; Hojo S; Ueda Y; Bandoh S; Yang Y; Yamaji Y; Ohtsuki Y; Ishida T
    Lung Cancer; 2001 Dec; 34(3):387-94. PubMed ID: 11714536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the release of CYFRA21-1 in human lung cancer cell lines.
    Dohmoto K; Hojo S; Fujita J; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
    Lung Cancer; 2000 Oct; 30(1):55-63. PubMed ID: 11008010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytokeratin 19 in human hepatocellular carcinoma cell lines.
    Wu F; Nishioka M; Fujita J; Murota M; Ohtsuki Y; Ishida T; Kuriyama S
    Int J Oncol; 2002 Jan; 20(1):31-7. PubMed ID: 11743639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines.
    Dohmoto K; Hojo S; Fujita J; Yang Y; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Ishida T; Takahara J
    Int J Cancer; 2001 Feb; 91(4):468-73. PubMed ID: 11251967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytokeratin 19 mRNA in human lung cancer cell lines.
    Ueda Y; Fujita J; Bandoh S; Hojo S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
    Int J Cancer; 1999 Jun; 81(6):939-43. PubMed ID: 10362142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
    Ruud P; Fodstad O; Hovig E
    Int J Cancer; 1999 Jan; 80(1):119-25. PubMed ID: 9935241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
    Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
    Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population.
    Farker K; Lehmann MH; Kästner R; Weber J; Janitzky V; Schubert J; Hoffmann A
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):30-4. PubMed ID: 10667834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
    Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
    Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
    Su C; Ye Y; Wang D; Cao X; Li S; Shan X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):37-40. PubMed ID: 11836684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
    Majumdar S; Diamandis EP
    Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma.
    Saintigny P; Coulon S; Kambouchner M; Ricci S; Martinot E; Danel C; Breau JL; Bernaudin JF
    Int J Cancer; 2005 Jul; 115(5):777-82. PubMed ID: 15729695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands.
    Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF
    Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promoter region of the human BUBR1 gene and its expression analysis in lung cancer.
    Seike M; Gemma A; Hosoya Y; Hosomi Y; Okano T; Kurimoto F; Uematsu K; Takenaka K; Yoshimura A; Shibuya M; Ui-Tei K; Kudoh S
    Lung Cancer; 2002 Dec; 38(3):229-34. PubMed ID: 12445743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.